Scandion Oncology
Overcoming cancer drug resistance
Navbar
Research & Development
Pipeline
Clinical Development
Science
Cancer drug resistance
Technology Platform
SCO-101
News & Press
Press releases
Investors
Share information
Financial calendar
Financial Reports
Annual reports
Interim reports
Presentations
Business development
Analyst Coverage
Prospectuses
Subscription warrants
Rights Issue 2024
Rights Issue 2022
Rights Issue 2020
Rights Issue 2019
Subscription Warrant (SCOL TO 1)
IPO 2018
Corporate governance
General meetings
Skip to content
DAF visit to Scandion
See the slide deck
here
.
Post navigation
Conference call on CORIST
Investor AW